BNTX - The Science Gives Moderna A Boost

• This article will explain some of the science that Moderna has developed behind their mRNA-based vaccines, including the COVID-19 vaccine.
• Moderna's platform research investments, digital backbone + manufacturing plants, and structured data collection are competitive advantages.
• Moderna has a 10X mindset and is ready to scale its success with the COVID-19 vaccine to other products.
• Moderna has just entered the middle portion of the S-curve and the best of the company's future is still ahead of them.
• Even though Moderna has potential competition in mRNA technology over the long term, it is a buy at current prices.

For further details see: